2021 MIPS Measure #309: Cervical Cancer Screening 

Measure Type High Priority Measure? Collection Type(s)
Process no eCQM


Measure Description

Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria:

  • Women age 21-64 who had cervical cytology performed every 3 years
  • Women age 30-64 who had cervical cytology/human papillomavirus (HPV) co-testing performed every 5 years


CMS-Family-Medicine-2021, CMS-Internal-Medicine-2021, CMS-Obstetrics-Gynecology-2021, Internal Medicine, Obstetrics/Gynecology, Quality-2021